A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
The products covered under the bill include beta-blockers for people with congestive heart failure, blood pressure monitors for people with hypertension, glucometers for people with diabetes, inhalers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback